A small study using umbilical cord blood stem cells to treat COVID-19 suggests that these stem cells could significantly improve survival rates and accelerate recovery time for critically ill COVID-19 patients. The study recently published in Stem Cells Translational...
2020 has been a difficult year. But the unprecedented challenges posed by the COVID-19 pandemic have also helped drive huge leaps forward in medical science. We’ve taken some time to reflect and summarise some of the significant advancements that have been made in the...
Initial data from early clinical trials show that mesenchymal stem cells could potentially stop the virus, calm the immune response and repair tissue damage caused by COVID-19. As the pandemic continues, the race is truly on to find an effective treatment for...
We are over halfway through 2020 and it’s fair to say that it has been an eventful year so far. We have summed up some of the key events over the past few months. Keep on reading to find out more… COVID-19 Update Over the last couple of months, we have been...
As we continue with Cord Blood Awareness month, we will reflect on some of the most revolutionary clinical trials using umbilical cord blood over the last two decades. Cord blood and brain injury Traumatic brain injury (TBI) is a major cause of disability and...
Cells4Life is proud to announce our membership of the All-Party Parliamentary Group for Longevity (APPG). Our aim is to deliver 5 extra years of healthy life expectancy to all British citizens by 2035 while minimising health inequalities. Regenerative medicine will...
